Our Services
Medical Information
Helpful Resources
Published on: 7/9/2026
GLP-1 medications support fat loss but may cause muscle loss without proper protein intake, energy balance, and exercise. To preserve lean mass, doctors recommend personalized protein targets (typically 1.2–2.0 g/kg body weight), structured resistance training 2–3 times weekly, regular body composition monitoring, and strategic nutrient timing around workouts.
Below, you'll find detailed guidance on nutrition, exercise protocols, warning signs of muscle loss, and key next steps to discuss with your healthcare team.
If you're taking a GLP-1 medication and noticing fatigue, weakness, or unexpected changes in your body, don't guess — these symptoms could signal muscle loss, nutrient deficiencies, or other issues that need attention. Take a free, instant, online symptom check to better understand what's happening and confidently navigate your next steps with your care team.
Reviewed for medical accuracy: 06/18/2026
GLP-1 receptor agonists (often just called "GLP-1 meds") are a powerful tool for weight management and blood sugar control. As these medications help you lose fat, there's a natural concern: could they also cause unwanted muscle loss? This guide covers why muscle loss can happen, what medical teams do to protect your lean tissue, and practical steps you can take.
Throughout, we'll keep things straightforward and avoid unnecessary jargon. If you ever feel concerned about symptoms or side effects, you can use Ubie's free AI-powered symptom checker to get personalized insights and help identify what might be happening. And remember: always speak to a doctor about anything that could be life-threatening or serious.
GLP-1 meds—like semaglutide or liraglutide—work by slowing gastric emptying, promoting fullness, and reducing appetite. While these effects help with fat loss, they can also contribute to muscle loss in some cases:
Understanding these factors helps you and your medical team take targeted steps to preserve muscle while benefiting from GLP-1 therapy.
Medical professionals use a combination of nutrition strategies, exercise prescriptions, and monitoring to safeguard your lean mass. Here's what they focus on:
You play a central role in preserving muscle while on GLP-1 meds. Here are actionable tips:
While some lean-mass loss is expected during weight reduction, rapid or excessive muscle loss can lead to weakness, fatigue, and decreased functional ability. Be alert for:
If you notice these symptoms developing, take Ubie's free AI symptom assessment to better understand what's happening and get guidance on next steps before your appointment.
Always consult a healthcare professional if you notice:
Your doctor can adjust your GLP-1 dosage, revise nutritional plans, or explore alternative therapies.
GLP-1 medications offer significant benefits for many people:
By pairing these drugs with thoughtful nutrition, exercise, and monitoring, medical teams work to minimize muscle loss while maximizing health improvements.
Remember, preserving muscle is a team effort—yours and your medical provider's. If you have questions or new symptoms, check your symptoms with Ubie's free AI tool and then discuss the results with your healthcare team. Always speak to a doctor about anything that could be life-threatening or serious.
Stay proactive, stay informed, and let your healthcare professionals guide you safely through your GLP-1 therapy journey.
(References)
* Ryan DH, et al. Weight Loss with GLP-1 Receptor Agonists and Changes in Body Composition: A Systematic Review and Meta-Analysis. *Obesity (Silver Spring)*. 2023 Dec;31(12):3049-3064. doi: 10.1002/oby.23891. Epub 2023 Sep 21. PMID: 37736411.
* Lim CH, et al. Impact of Glucagon-Like Peptide-1 Receptor Agonists on Body Composition in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis. *Diabetes Metab J*. 2022 Sep;46(5):713-726. doi: 10.4093/dmj.2021.0360. Epub 2022 Sep 27. PMID: 36173059.
* Hjorth M, et al. Glucagon-like peptide-1 receptor agonists and sarcopenia: a critical review. *Eur J Endocrinol*. 2023 Mar 15;188(4):R57-R70. doi: 10.1530/EJE-22-0941. PMID: 36625807.
* Wilding JPH, et al. Strategies to mitigate muscle mass loss during weight reduction: a focus on GLP-1 receptor agonists. *Obes Rev*. 2024 Apr;25(4):e13673. doi: 10.1111/obr.13673. Epub 2024 Jan 20. PMID: 38243758.
* Chrzanowski M, et al. Interventions to Mitigate Lean Mass Loss During Pharmacological Weight Loss: A Narrative Review. *Obes Surg*. 2024 Apr;34(4):1454-1463. doi: 10.1007/s11695-024-06990-2. Epub 2024 Feb 24. PMID: 38400030.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.